Session Details

U052 Mechanisms and Management of Dermatitis in the Older Patient

Sat, Mar 9, 4:30 PM - 5:30 PM
Room 20B
1 CME Available Focus Session NEW
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Over a third of patients seeing dermatologists are over 65, and more than half are older than 50 years of age. Over time, there are changes in the immune system and the skin barrier to favor the development of dermatitis, while management can be more complicated with comorbid conditions and medications. The goal of this session is to provide practicing dermatologists a foundation of the pathophysiologic mechanisms driving dermatitis symptoms in older patients, diagnostic tools to make the diagnosis, as well as optimal management strategies accounting for age and comorbidities including introduction of the 4Ms of geriatric disease management.

LEARNING OBJECTIVES

1.

Describe mechanisms of the aging immune system.

2.

Differentiate possible causes of dermatitis in the older patient.

3.

Optimize management strategies for dermatitis in the older patient.

SCHEDULE

12:30 AM

Skin changes and immunology of pruritus and dermatitis in aging skin

Kevin C. Wang, MD, PhD, FAAD

12:50 AM

Therapeutic management in the older patient

Anne Lynn S. Chang, MD, FAAD

1:10 AM

Workup and discussion of management of dermatitis in the older patient

Peggy Wu, MPH, MD, FAAD

SPEAKERS

Anne Lynn S. Chang, MD, FAAD

Anne Lynn S. Chang, MD, FAAD

Kevin C. Wang, MD, PhD, FAAD

Kevin C. Wang, MD, PhD, FAAD

Peggy Wu, MPH, MD, FAAD

Peggy Wu, MPH, MD, FAAD

SPEAKER DISCLOSURES

Anne Lynn S. Chang, MD, FAAD

Castle Biosciences – Advisory Board(Honoraria); Feldan Therapeutics – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Genentech, Inc. – Investigator(Grants/Research Funding); Jounce Therapeutics, Inc. – Advisory Board(Honoraria); Merck & Co., Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Nuskin – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Senhwa Biosciences, Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);

Kevin C. Wang, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Peggy Wu, MPH, MD, FAAD

American Academy of Dermatology – Other(No Compensation Received); UpToDate, Inc – Other(Honoraria);